Access to Zofin for patients with COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial provides expanded access to an investigational treatment called Zofin for patients with mild to moderate COVID-19 symptoms. The goal is to see if it can help ease symptoms and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a positive COVID-19 test (PCR test).
- You must have mild or moderate COVID-19 symptoms like fever, cough, tiredness, or muscle aches.
- You must not have severe breathing problems from COVID-19.
- If you are a woman who can have children, you must agree to use birth control during the study and for 6 months after.
- Men must agree to use contraception and not donate sperm during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an antiviral medicine called FS-1 (brand name Efesovir) in adults hospitalized with COVID-19 who have risk factors for severe illness. The goal is to see if the drug can help them recover faster or avoid more serious complications.
This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.
This early-stage study tests COVID-19 treatments in people who have recently developed symptoms and who test positive for the virus. It aims to find safer, more effective options for preventing worsening disease, especially in higher-risk groups.
This trial tests an oral drug called SPI-1005 for people hospitalized with moderate COVID-19. The drug may help reduce inflammation and protect the lungs, and the study will compare it to a placebo (a pill with no active medicine) to see if it helps people recover.
This trial tests whether the medicine nitazoxanide, taken as a pill, can help people with mild COVID-19 or flu feel better faster and prevent complications. It is designed for people who are generally healthy and can be treated at home.
This trial tests whether Codivir can help people hospitalized with moderate COVID-19 recover better than a placebo (inactive pill). It will compare outcomes while participants receive standard hospital care.
Hear when a new Covid19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.